Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24324416)

1.

Rodent models of Parkinson's disease: beyond the motor symptomatology.

Campos FL, Carvalho MM, Cristovão AC, Je G, Baltazar G, Salgado AJ, Kim YS, Sousa N.

Front Behav Neurosci. 2013 Nov 26;7:175. doi: 10.3389/fnbeh.2013.00175. eCollection 2013.

2.

Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Lee HM, Koh SB.

J Mov Disord. 2015 May;8(2):92-7. doi: 10.14802/jmd.15003. Epub 2015 May 31. Review.

3.

Non-motor signs in Parkinson's disease: a review.

Munhoz RP, Moro A, Silveira-Moriyama L, Teive HA.

Arq Neuropsiquiatr. 2015 May;73(5):454-62. doi: 10.1590/0004-282X20150029. Epub 2015 Apr 17.

4.

The nonsteroidal antiinflammatory drug piroxicam reverses the onset of depressive-like behavior in 6-OHDA animal model of Parkinson's disease.

Santiago RM, Tonin FS, Barbiero J, Zaminelli T, Boschen SL, Andreatini R, Da Cunha C, Lima MM, Vital MA.

Neuroscience. 2015 Aug 6;300:246-53. doi: 10.1016/j.neuroscience.2015.05.030. Epub 2015 May 18.

PMID:
25999296
5.

Parkinson's disease: a review of non-motor symptoms.

Rana AQ, Ahmed US, Chaudry ZM, Vasan S.

Expert Rev Neurother. 2015 May;15(5):549-62. doi: 10.1586/14737175.2015.1038244.

PMID:
25936847
6.

Characterization of long-term motor deficits in the 6-OHDA model of Parkinson's disease in the common marmoset.

Santana M, Palmér T, Simplício H, Fuentes R, Petersson P.

Behav Brain Res. 2015 Sep 1;290:90-101. doi: 10.1016/j.bbr.2015.04.037. Epub 2015 Apr 28.

PMID:
25934488
7.

Non-motor signs in Parkinson's disease: a review.

Munhoz RP, Moro A, Silveira-Moriyama L, Teive HA.

Arq Neuropsiquiatr. 2015 Apr 17:0. [Epub ahead of print]

8.

Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein.

Bentea E, Van der Perren A, Van Liefferinge J, El Arfani A, Albertini G, Demuyser T, Merckx E, Michotte Y, Smolders I, Baekelandt V, Massie A.

Front Behav Neurosci. 2015 Mar 31;9:68. doi: 10.3389/fnbeh.2015.00068. eCollection 2015.

9.

Respiratory deficits in a rat model of Parkinson's disease.

Tuppy M, Barna BF, Alves-Dos-Santos L, Britto LR, Chiavegatto S, Moreira TS, Takakura AC.

Neuroscience. 2015 Jun 25;297:194-204. doi: 10.1016/j.neuroscience.2015.03.048. Epub 2015 Mar 30.

PMID:
25838118
10.

Irisflorentin improves α-synuclein accumulation and attenuates 6-OHDA-induced dopaminergic neuron degeneration, implication for Parkinson's disease therapy.

Chen YM, Liu SP, Lin HL, Chan MC, Chen YC, Huang YL, Tsai MC, Fu RH.

Biomedicine (Taipei). 2015;5(1):4. doi: 10.7603/s40681-015-0004-y. Epub 2015 Feb 2.

11.

Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.

Cai H, Liu G, Sun L, Ding J.

Transl Neurodegener. 2014 Dec 10;3:27. doi: 10.1186/2047-9158-3-27. eCollection 2014. Review.

12.

A time-course study of behavioral and electrophysiological characteristics in a mouse model of different stages of Parkinson's disease using 6-hydroxydopamine.

Park SE, Song KI, Suh JK, Hwang D, Youn I.

Behav Brain Res. 2015 May 1;284:153-7. doi: 10.1016/j.bbr.2015.02.019. Epub 2015 Feb 16.

PMID:
25698596
13.

Longitudinal follow-up and characterization of a robust rat model for Parkinson's disease based on overexpression of alpha-synuclein with adeno-associated viral vectors.

Van der Perren A, Toelen J, Casteels C, Macchi F, Van Rompuy AS, Sarre S, Casadei N, Nuber S, Himmelreich U, Osorio Garcia MI, Michotte Y, D'Hooge R, Bormans G, Van Laere K, Gijsbers R, Van den Haute C, Debyser Z, Baekelandt V.

Neurobiol Aging. 2015 Mar;36(3):1543-58. doi: 10.1016/j.neurobiolaging.2014.11.015. Epub 2014 Dec 17.

PMID:
25599874
14.

Selenium reduces bradykinesia and DNA damage in a rat model of Parkinson's disease.

Ellwanger JH, Molz P, Dallemole DR, Pereira dos Santos A, Müller TE, Cappelletti L, Gonçalves da Silva M, Franke SI, Prá D, Pêgas Henriques JA.

Nutrition. 2015 Feb;31(2):359-65. doi: 10.1016/j.nut.2014.07.004. Epub 2014 Jul 30.

PMID:
25592015
15.

Early Parkinson's disease symptoms in α-synuclein transgenic monkeys.

Niu Y, Guo X, Chen Y, Wang CE, Gao J, Yang W, Kang Y, Si W, Wang H, Yang SH, Li S, Ji W, Li XJ.

Hum Mol Genet. 2015 Apr 15;24(8):2308-17. doi: 10.1093/hmg/ddu748. Epub 2014 Dec 30.

PMID:
25552648
16.

PPARβ/δ and γ in a rat model of Parkinson's disease: possible involvement in PD symptoms.

Falcone R, Florio TM, Di Giacomo E, Benedetti E, Cristiano L, Antonosante A, Fidoamore A, Massimi M, Alecci M, Ippoliti R, Giordano A, Cimini A.

J Cell Biochem. 2015 May;116(5):844-55. doi: 10.1002/jcb.25041.

PMID:
25530507
17.

Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease.

Kumari R, Kumar JB, Luthra PM.

Neurosci Lett. 2015 Mar 4;589:191-5. doi: 10.1016/j.neulet.2014.12.030. Epub 2014 Dec 17.

PMID:
25528406
18.

Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys.

Chen M, Wang T, Yue F, Li X, Wang P, Li Y, Chan P, Yu S.

Neuroscience. 2015 Feb 12;286:383-92. doi: 10.1016/j.neuroscience.2014.12.003. Epub 2014 Dec 10.

PMID:
25498223
19.

A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.

Bonito-Oliva A, Masini D, Fisone G.

Front Behav Neurosci. 2014 Aug 27;8:290. doi: 10.3389/fnbeh.2014.00290. eCollection 2014.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk